There is controversy around the FDA approval of a new Alzheimer's drug - Aduhelm. Eugenia Welch, President and CEO of Alzheimer's San Diego discusses on the FOUR.
KFMB would like to send you push notifications about the latest news and weather.
Notifications can be turned off anytime in the browser settings.
